A5064597021- Diabetes Management and Research
- Pancreatic function and diabetes
- Diabetes and associated disorders
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Genomics and Rare Diseases
- COVID-19 and Mental Health
- Long-Term Effects of COVID-19
- Genetics and Neurodevelopmental Disorders
- Diet, Metabolism, and Disease
- COVID-19 Clinical Research Studies
Jagiellonian University
2018-2023
Krakow Cardiovascular Research Institute
2019-2022
Objectives. To evaluate the spectrum of neurological symptoms in patients with COVID-19 during first 14 days hospitalisation and its association in-hospital mortality. Material methods. We included 200 RT-PCR-confirmed admitted to University Hospital Krakow, Poland. In 164 patients, a detailed questionnaire concerning signs was performed prospectively within hospitalisation. remaining 36 such questionnaires were completed retrospectively based on daily observations Department Neurology....
Lipohypertrophy (LH) of subcutaneous tissue is an insulin-induced complication occurring in patients with diabetes. We aimed to define the prevalence LH and identify its risk factors type 1 diabetes (T1DM) treated continuous insulin infusion (CSII). The study included 79 consecutive CSII-treated T1DM patients. diagnose was based on ultrasonography (US) as a reference method, physical examination also performed. Clinical characteristics were available from medical records. median age 28 years...
To investigate the utility of biomarkers maturity-onset diabetes young (MODY), high-sensitivity C-reactive protein (hsCRP), and 1,5-anhydroglucitol (1,5-AG) in conjunction with other clinical laboratory features to improve diagnostic accuracy provide a algorithm for HNF1A MODY.We examined 77 patients MODY, 88 GCK MODY mutations, 99 type 1 diabetes, 92 2 diabetes. In addition 1,5-AG hsCRP, we considered body mass index (BMI), fasting glucose, serum C-peptide as potential biomarkers. Logistic...
Abstract Aim The impact of maturity onset diabetes the young (MODY) on quality life (QoL) has never been examined. We assessed disease QoL among patients with HNF1A-MODY and GCK mutation carrier status. Methods study included 80 89 gene carriers. also examined 128 type 1 (T1DM) for comparison. Diabetes-specific was using Audit Diabetes Dependent Quality Life questionnaire. Results GCK-MODY groups had similar mean age (41.7 vs. 38.0 years, respectively) BMI (24.1 24.3 kg/m 2 ), whereas T1DM...
Fear of hypoglycaemia seems to be one the strongest barrier physical activity for individuals with type 1 diabetes mellitus (T1DM).The aim study was describe clinical characteristics participants T1DM in intense sporting event runs and bike rides"SPORTGIVECHANCE-Diabetic runners cyclists more sport all Europe", investigate factors associated self-reported episodes during competition, particular use continuous flash glucose monitoring systems (CGM/FGM).The took place Spoleto, Italy from 30...
Maturity-onset diabetes of the young (MODY) accounts for 1-2% all cases. Unfortunately, circa 90% MODY cases are misdiagnosed as type 1 or 2 diabetes. A proper genetic diagnosis based on automatic sequencing is crucial use a tailored treatment. However, this method still expensive and, thus, patients' selection testing should be performed precisely. In 2012, an easy-to-use tool was developed in Exeter, UK, to support British population. The aim study assess utility Probability Calculator...
MODY accounts for 1-2% of all diabetes cases. There are more than 20 genes linked with MODY. Unfortunately, ca. 90% cases misdiagnosed as type 1 or 2 diabetes. A proper diagnosis the is crucial use a tailored treatment. Next-generation sequencing (NGS) enables simultaneous testing set responsible However, this method still not reimbursed in many countries and patients' selection should be performed preciously. In 2012, an easy-to-use tool have been developed Exeter, UK, to support...
I n t r o d u c i n: Proper use of insulin infusion sets (IIS) plays an important role in pump therapy patients with type 1 diabetes mellitus (T1DM).We assessed the habits associated IIS T1DM treated pump.M a e l s M h s: This study included 79 who were examined for presence lipohypertrophy (LH) and retrained proper use.They completed standard questionnaire regarding at time entry follow-up.R At baseline, most declared to have been using plastic cannula (n = 68; 86.1%), changing set...
Introduction: Hypoglycemia fear seems to be the strongest barrier physical activity for individuals with type 1 diabetes mellitus (T1DM). The aim of study was describe clinical characteristics participants T1DM in intensive sporting event runs and bike rides, investigate factors associated reported hypoglycemia events during competition, particular use continuous flash glucose monitoring systems (CGM/FGM). Methods: took place Spoleto, Italy from 30 August 2 September 2018. An online survey...